Is it ethical for wealthy countries to stockpile vaccines and treatments during a global health emergency?
No, it is not ethical at all. Far from it, even. Ask the average person, and they would most likely answer that it is “obviously” not ethical for wealthy countries to hoard medicine and treatment in any situation, much less during a global health emergency. By actively hoarding what could very well save hundreds and thousands of people, a country that hoards would end up having more blood on their hands from those who are less fortunate. But why is that? Why is it unethical? Scratch that, why do countries even hoard to begin with? What about those who aren’t as fortunate to be able to live in those wealthy countries?
When a country obtains vaccines and treatments, it should obviously be able to ration it so that all citizens could access it equally and easily. But what happens when a country has more than needed? That means the country has more than enough to secure the health for its citizens, which is good! But then, what about other countries? An example of countries hoarding treatment in the form of vaccines specifically happened just recently: during the COVID-19 pandemic. According to People’s Vaccine Alliance, countries like Canada bought enough vaccines to protect their citizens 3 to 5 times over, despite the main supplier for the vaccines at the time, Oxford-AstraZeneca, promising to provide 64% of their vaccines to developing countries.
Specifically, the same article by BBC states “Canada, for example, has ordered enough vaccines to protect each Canadian five times, it claims”. Ordered here is the key word. Do you see it? “Ordered enough vaccines” means they purchased the vaccines, did they not? This process is similar to pre-ordering an item from a shop, similar to the down-payments on exclusive items like figurines, etc. Just like how you would pay a down-payment for an item you want, countries also do this, but on a larger scale with treatments and vaccines alongside companies, thanks to the help of contracts and agreements like the Advance Purchase Agreement (APA).
An Advanced Purchase Agreement is essentially a contract that commits a country to buying a certain amount of doses, which indirectly funds its research by de-risking capital investment. In other words, for companies that develop vaccines, the question shifts from spending a billion dollars for a market that may not exist, to spending a billion dollars for a market that is contractually guaranteed if they succeed. Like in the paragraphs above, an example of this is when SARS-Cov-2 (the virus that results in the Covid-19 disease) was discovered and started spreading amongst citizens (confirmed Covid-19 cases in the US near the time of this APA agreement reached nearly 4 million), the US and Pharmaceutical companies Pfizer and BioNTech signed an APA that states that the Department of Defense will pay the two companies a combined total of $1.95B, and in exchange, they promise to give the US the first 100 million doses upon approval that the doses were safe for citizens, along with the option to order an additional 500 million doses. This example is not the only one, and there are many other such examples of APAs like this being used to prioritize their citizens.
While it is good that a country is taking action for their citizens by actively pre-ordering vaccines and treatments while still in their clinical trials (hence also helping with the research and production of the treatments), there is definitely a limit when it comes to simply “ordering enough to make sure there are enough treatments for your country’s citizens”, and ordering enough to treat their citizens 3 to 5 times over, assuming all vaccinations and treatments are valid and safe for use, is definitely too much. Especially considering how, especially during a global health emergency, all countries need as many treatments as they can get with what amount they have, it would not be fair for those wealthier to be able to essentially buy out the available treatments during the time where it is most needed, that time being as soon as possible. Ultimately, it is the advantage of wealthy countries, and the disadvantage of lower-middle income countries.
But that then brings the question, why would a country want to hoard medicine to begin with? Well, the most obvious reason is to bring reassurance that there is enough medicine to go by for its citizens. If you are to think from the countries’ perspective, it makes sense to hoard as much. There are factors like future pandemics that might happen, or just the fact that countries naturally have a duty to think and prioritize their citizens above all. However, there is definitely a limit to that, a limit that is not as far as enough treatment to cure their citizens three to five times over. Yes, a country should obviously prioritize their citizens, but it would be unfair for only the rich countries to hog a good portion of available treatments, and leave other countries who are unable to obtain the medicine to only be able to get so many.
It is as the usual proverb normally goes, there can indeed be “too much of a good thing”. Medicines for Europe argues that stockpiling treatment is not the solution to medicine shortages, because, by actively hoarding said medicine, the country would then be actively contributing to the shortage in medicine, specifically for other countries. To put a number on this point, around 240 million Covid-19 vaccine doses purchased by wealthy countries were expected to go unused and expire by early 2022, while more than a third of the world had yet to receive a first dose. Along with that, there are consequences that come with having so many unused medicines and treatments, like additional costs, the cost of maintaining and preserving treatments that are yet to be used, creating a false sense of security during a global emergency, et cetera.
In conclusion, it is not ethical for wealthy countries to hoard treatments and vaccines for itself, because it directly blocks countries “below” it from obtaining the same treatment that is used to save lives. Yes, a country has an obligation to put their own citizens first above other countries, and it is good if a country does prioritize their citizens, but keeping enough treatment to treat the entire country’s population multiple times over is definitely overkill and counterproductive in a “save as many people globally as possible” way, as hoarding treatments instead potentially leads to more deaths in other countries. Not only that, there are also side effects to hoarding medicine, like the amount of money it costs to keep the treatments so they are safe to use for future cases, and so on. A country should (and has an obligation to) prioritize its citizens first, but it must also not forget the other countries that are also looking for the same things as them, so that everyone can be treated globally, not just their citizens alone.
BIBLIOGRAPHY



